Skip to main content
All lobbying clients

ALKERMES, INC.

Lobbying client · Massachusetts · filed 2025 to 2026

$5,920,000 Reported spend
6 Filings counted
1 Firms hired
15 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (191188), not by name.

 Firms hired 1
 Bills named in these filings 15
  • HR 4030
    Treatment Continuity Act of 2025
    5 filings
  • HR 2163
    Safe Step Act
    4 filings
  • S 464
    Safe Step Act
    4 filings
  • HR 1414
    Cameron’s Law
    4 filings
  • HR 946
    ORPHAN Cures Act
    4 filings
  • HR 1
    Lower Energy Costs Act
    2 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    2 filings
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…
    2 filings
  • S 2903
    Safe Step Act
    2 filings
  • HR 4780
    USTRx Act
    1 filing
  • HR 5509
    Safe Step Act
    1 filing
  • HR 7148
    Consolidated Appropriations Act, 2026
    1 filing
  • HR 8469
    Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for…
    1 filing
  • HR 8845
    Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
    1 filing
  • HR 9260
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
    1 filing
 Reported by year 2 years
  • 2026 $1,960,000 2 filings
  • 2025 $3,960,000 4 filings
 Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 10
  • Centers For Medicare and Medicaid Services (CMS) 6
  • Executive Office of the President (EOP) 6
  • Health & Human Services, Dept of (HHS) 6
  • HOUSE OF REPRESENTATIVES 6
  • Justice, Dept of (DOJ) 6
  • Natl Institutes of Health (NIH) 6
  • Office of Natl Drug Control Policy (NDCP) 6
  • SENATE 6
  • Substance Abuse & Mental Health Services Administration (SAMHSA) 6
  • Veterans Affairs, Dept of (VA) 6
 Recent filings 6 total
Q2
ALKERMES, INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $930,000 expenses · posted Jul 20, 2026
View → Q1
ALKERMES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $1,030,000 expenses · posted Apr 20, 2026
View → Q4
ALKERMES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $870,000 expenses · posted Jan 20, 2026
View → Q3
ALKERMES, INC.
3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $840,000 expenses · posted Oct 20, 2025
View → Q2
ALKERMES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $830,000 expenses · posted Jul 18, 2025
View → Q1
ALKERMES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $1,420,000 expenses · posted Apr 18, 2025
View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem